Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country/Region, 2017, 2022 & 2028

2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type

2.2.1 Control Hyperphosphatemia

2.2.2 Maintain Blood Calcium Levels

2.2.3 Control PTH Level

2.2.4 Correct Acidosis

2.2.5 Other

2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type

2.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2022)

2.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2017-2022)

2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.4.4 Drug Stores 

2.4.5 Other

2.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application

2.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2017-2022)

2.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2017-2022)

3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Company

3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Breakdown Data by Company

3.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Company (2020-2022)

3.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2020-2022)

3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Company (2020-2022)

3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2020-2022)

3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2020-2022)

3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company

3.4 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Location Distribution

3.4.2 Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Geographic Region

4.1 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Geographic Region (2017-2022)

4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Geographic Region

4.2 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country/Region (2017-2022)

4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Country/Region

4.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth

4.4 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth

4.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth

4.6 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth

5 Americas

5.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country

5.1.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022)

5.1.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022)

5.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type

5.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region

6.1.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2017-2022)

6.1.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2022)

6.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type

6.3 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country

7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022)

7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022)

7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type

7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country

8.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022)

8.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type

8.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

10.3 Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

10.4 Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors

11.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer

12 World Forecast Review for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Geographic Region

12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Region

12.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Region (2023-2028)

12.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type

12.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application

13 Key Players Analysis

13.1 Akebia

13.1.1 Akebia Company Information

13.1.2 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Akebia Main Business Overview

13.1.5 Akebia Latest Developments

13.2 Astellas

13.2.1 Astellas Company Information

13.2.2 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Astellas Main Business Overview

13.2.5 Astellas Latest Developments

13.3 Takeda

13.3.1 Takeda Company Information

13.3.2 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Takeda Main Business Overview

13.3.5 Takeda Latest Developments

13.4 Vifor

13.4.1 Vifor Company Information

13.4.2 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Vifor Main Business Overview

13.4.5 Vifor Latest Developments

13.5 Abbvie

13.5.1 Abbvie Company Information

13.5.2 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abbvie Main Business Overview

13.5.5 Abbvie Latest Developments

13.6 Fresenius

13.6.1 Fresenius Company Information

13.6.2 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fresenius Main Business Overview

13.6.5 Fresenius Latest Developments

13.7 Abbott

13.7.1 Abbott Company Information

13.7.2 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Abbott Main Business Overview

13.7.5 Abbott Latest Developments

13.8 Novadiol

13.8.1 Novadiol Company Information

13.8.2 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novadiol Main Business Overview

13.8.5 Novadiol Latest Developments

13.9 Japan Tobacco Company

13.9.1 Japan Tobacco Company Company Information

13.9.2 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Japan Tobacco Company Main Business Overview

13.9.5 Japan Tobacco Company Latest Developments

13.10 Daiichi-Sankyo

13.10.1 Daiichi-Sankyo Company Information

13.10.2 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Daiichi-Sankyo Main Business Overview

13.10.5 Daiichi-Sankyo Latest Developments

13.11 Shield

13.11.1 Shield Company Information

13.11.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shield Main Business Overview

13.11.5 Shield Latest Developments

13.12 Spectrum

13.12.1 Spectrum Company Information

13.12.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Spectrum Main Business Overview

13.12.5 Spectrum Latest Developments

13.13 OPKO

13.13.1 OPKO Company Information

13.13.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 OPKO Main Business Overview

13.13.5 OPKO Latest Developments

13.14 Ardelyx

13.14.1 Ardelyx Company Information

13.14.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Ardelyx Main Business Overview

13.14.5 Ardelyx Latest Developments

13.15 Sanofi Genzyme

13.15.1 Sanofi Genzyme Company Information

13.15.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Sanofi Genzyme Main Business Overview

13.15.5 Sanofi Genzyme Latest Developments

13.16 Amgen

13.16.1 Amgen Company Information

13.16.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

13.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Amgen Main Business Overview

13.16.5 Amgen Latest Developments

14 Research Findings and Conclusion

Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Control Hyperphosphatemia

Table 4. Major Players of Maintain Blood Calcium Levels

Table 5. Major Players of Control PTH Level

Table 6. Major Players of Correct Acidosis

Table 7. Major Players of Other

Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)

Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2022)

Table 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2022) & ($ million)

Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2017-2022)

Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2017-2022) & (USD/Kg)

Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)

Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2022)

Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2022)

Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2017-2022)

Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2017-2022) & (USD/Kg)

Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2020-2022) & (MT)

Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2020-2022)

Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2020-2022)

Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company (2020-2022) & (USD/Kg)

Table 23. Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution and Sales Area

Table 24. Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered

Table 25. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Geographic Region (2017-2022) & (MT)

Table 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Geographic Region (2017-2022)

Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country/Region (2017-2022) & (MT)

Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2017-2022)

Table 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022) & (MT)

Table 37. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2017-2022)

Table 38. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2017-2022)

Table 40. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)

Table 41. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2022)

Table 42. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)

Table 43. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2022)

Table 44. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2017-2022) & (MT)

Table 45. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2017-2022)

Table 46. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2017-2022)

Table 48. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)

Table 49. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2022)

Table 50. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)

Table 51. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2022)

Table 52. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022) & (MT)

Table 53. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2017-2022)

Table 54. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2017-2022)

Table 56. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)

Table 57. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2022)

Table 58. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)

Table 59. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022) & (MT)

Table 61. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)

Table 65. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)

Table 67. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Table 69. Key Market Challenges & Risks of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Table 70. Key Industry Trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Table 71. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List

Table 74. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer List

Table 75. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2023-2028) & (MT)

Table 76. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Forecast by Region

Table 77. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2023-2028) & (MT)

Table 80. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2023-2028) & (MT)

Table 82. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2023-2028) & (MT)

Table 84. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2023-2028) & (MT)

Table 86. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2023-2028) & (MT)

Table 88. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2023-2028) & (MT)

Table 92. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Application (2023-2028)

Table 95. Akebia Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 96. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 97. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 98. Akebia Main Business

Table 99. Akebia Latest Developments

Table 100. Astellas Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 101. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 102. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 103. Astellas Main Business

Table 104. Astellas Latest Developments

Table 105. Takeda Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 106. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 107. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 108. Takeda Main Business

Table 109. Takeda Latest Developments

Table 110. Vifor Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 111. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 112. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 113. Vifor Main Business

Table 114. Vifor Latest Developments

Table 115. Abbvie Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 116. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 117. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 118. Abbvie Main Business

Table 119. Abbvie Latest Developments

Table 120. Fresenius Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 121. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 122. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 123. Fresenius Main Business

Table 124. Fresenius Latest Developments

Table 125. Abbott Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 126. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 127. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 128. Abbott Main Business

Table 129. Abbott Latest Developments

Table 130. Novadiol Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 131. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 132. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 133. Novadiol Main Business

Table 134. Novadiol Latest Developments

Table 135. Japan Tobacco Company Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 136. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 137. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 138. Japan Tobacco Company Main Business

Table 139. Japan Tobacco Company Latest Developments

Table 140. Daiichi-Sankyo Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 141. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 142. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 143. Daiichi-Sankyo Main Business

Table 144. Daiichi-Sankyo Latest Developments

Table 145. Shield Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 146. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 147. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 148. Shield Main Business

Table 149. Shield Latest Developments

Table 150. Spectrum Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 151. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 152. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 153. Spectrum Main Business

Table 154. Spectrum Latest Developments

Table 155. OPKO Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 156. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 157. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 158. OPKO Main Business

Table 159. OPKO Latest Developments

Table 160. Ardelyx Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 161. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 162. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 163. Ardelyx Main Business

Table 164. Ardelyx Latest Developments

Table 165. Sanofi Genzyme Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 166. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 167. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 168. Sanofi Genzyme Main Business

Table 169. Sanofi Genzyme Latest Developments

Table 170. Amgen Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors

Table 171. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered

Table 172. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 173. Amgen Main Business

Table 174. Amgen Latest Developments

List of Figures

Figure 1. Picture of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Figure 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Control Hyperphosphatemia

Figure 10. Product Picture of Maintain Blood Calcium Levels

Figure 11. Product Picture of Control PTH Level

Figure 12. Product Picture of Correct Acidosis

Figure 13. Product Picture of Other

Figure 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2021

Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2017-2022)

Figure 16. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Hospital Pharmacies

Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Hospital Pharmacies (2017-2022) & (MT)

Figure 18. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Retail Pharmacies

Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Retail Pharmacies (2017-2022) & (MT)

Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Online Pharmacies

Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Online Pharmacies (2017-2022) & (MT)

Figure 22. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Drug Stores 

Figure 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Drug Stores  (2017-2022) & (MT)

Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Other

Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Other (2017-2022) & (MT)

Figure 26. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2022)

Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2021

Figure 28. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company in 2021

Figure 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region in 2021

Figure 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2017-2022)

Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country/Region in 2021

Figure 34. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2017-2022 (MT)

Figure 35. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2017-2022 ($ Millions)

Figure 36. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2017-2022 (MT)

Figure 37. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2017-2022 ($ Millions)

Figure 38. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2017-2022 (MT)

Figure 39. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2017-2022 (MT)

Figure 41. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2017-2022 ($ Millions)

Figure 42. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2021

Figure 43. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2021

Figure 44. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2021

Figure 49. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Regions in 2021

Figure 50. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2021

Figure 57. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2021

Figure 58. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2021

Figure 65. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2021

Figure 71. Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Figure 72. Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles